Previous Article | Next Article ![]()
Applied and Environmental Microbiology, June 2003, p. 3344-3349, Vol. 69, No. 6
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.6.3344-3349.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Plant Pathology and Microbiology,1 Entomological Sciences, Horticulture Research International, Wellesbourne, Warwick CV35 9EF, United Kingdom2
Received 13 December 2002/ Accepted 11 March 2003
|
|
|---|
|
|
|---|
Genes homologous to those present on CHRIM1 have also been described in Photorhabdus luminescens (1, 10), a symbiont of entomopathogenic nematodes closely related to Xenorhabdus species. The requirement of three genes equivalent to xptA1, xptB1, and xptC1 in the expression of full insecticidal activity towards the model insect Manduca sexta (tobacco hornworm) was shown first in P. luminescens strain Hb (10) and later in P. luminescens strain W14 (13). Homologous genes to xptA1, xptB1, and xptC1 have also been identified in Serratia entomophila (7), where some species are the causative agent of the chronic Amber disease in the New Zealand grass grub (8). Three plasmid-encoded genes, sepA, sepB, and sepC, homologous to xptA1, xptB1, and xptC1, were all required to be expressed in the same E. coli cell to induce full disease symptoms (7). In this previous work individual clones of each gene expressed from E. coli promoters could not be obtained due to rearrangements within the constructs. In this study we have expressed four xpt genes individually in E. coli: xptA1 (tcdA/sepA-like; 7,841 bp; 287-kDa predicted protein), xptA2 (tcdA/sepA-like; 7,647 bp; 285-kDa predicted protein), xptB1 (tccC/sepC-like; 3,047 bp; 111-kDa predicted protein), and xptC1 (tcdB/sepC-like, 4,256 bp; 160-kDa predicted protein). We have also determined which combinations of these genes need to be expressed for activity against different insect species. Gene disruptions in Xenorhabdus strains have also been produced to determine if similar interactions of the gene products occur in the wild-type strain. These aspects of Xenorhabdus insect toxins have not been addressed in earlier work. In addition the effect of the toxin complexes on four commercial pests have been studied in this work. With the potential of these genes for use in insect control, it is important that these points are addressed. In order to achieve this each of the xpt genes from PMFI296 were cloned individually into E. coli under the control of the
PL promoter, and cloned in combinations on the same vector, or on different vectors using the PLAC promoter in the same cell. Cells and cell lysates were used individually or mixed prior to inclusion into insect bioassays.
|
|
|---|
DNA purification and subcloning.
Plasmid DNA was prepared by the Qiagen (Dorking, United Kingdom) midi and Qiawell 8 (Qiagen) systems. Restriction digests were performed using the manufacturers' recommended conditions (Boehringer Mannheim, Lewes, United Kingdom; Life Technologies, Paisley, United Kingdom) and analyzed by agarose gel electrophoresis. After digestion, DNA was purified for cloning using the Qiagen PCR product clean-up system, following the manufacturer's recommended conditions (Qiagen). Blunt ending of DNA was performed using 1 U of Klenow (Life Technologies) in recommended buffer with 0.015 mM concentrations of deoxynucleoside triphosphates for 15 min at room temperature. The Klenow enzyme was inactivated by heating at 70°C for 10 min. All subcloning was carried out in E. coli, and DNA was electroporated into strains (12.5 kVcm2) using a Bio-Rad GenePulser. Clones were selected on LB or RMG plates containing the appropriate antibiotics.
Cloning and expression of toxin genes.
The construction of PL-xptA1 in plasmid pHRIM801 has been described elsewhere (12) and consists of the xptA1 gene placed downstream of the
PL promoter in the E. coli strain GI724, where the cI element is present on the chromosome under the control of the trp operon (Invitrogen). The plasmid pHRI802 (PL-xptA2) was created by cloning an 8,788-bp KpnI/EcoRI fragment, containing the entire xptA2 gene from cosmid CHRIM1, into pLEX cut with KpnI/EcoRI. The plasmid pHRIM803 (PLAC-B1/C1) was created from p338/2-AT2-191, an AT-2 transposon insertion mutation of clone 338/2 (12). The point of AT-2 insertion was identified as 171 bp upstream of the start codon of the xptC1 gene in the following sequence GGA GAG CCT GAG CGA TAT CAT TCT GCA TAT CCG CT, such that ATATC was duplicated during transposition. A 9,708-bp fragment containing both the xptB1 and xptC1 genes was excised from p338/2-Tm191 with BamHI and BglII and cloned into the BamHI site of pMCS-BBRC-1 such that the xptB1 and xptC1 genes were in the correct orientation for expression from the lac promoter of pMCS-BBRC-1. Plasmid pHRIM804 (PL-xptB1/C1) was similarly constructed by cloning the BamHI/BglII fragment into the BamHI site of pLEX. The plasmid pHRIM805 (PL-xptB1) was created by cutting pHRIM804 with ClaI and BamHI, treating with Klenow, and religating, thus removing a 4,521-bp fragment containing the majority of the xptC1 gene. PHRIM806 (PLAC-xptB1) was created by cutting pHRIM603 with ClaI and religating, thus again removing a 4,557-bp fragment containing the majority of the xptC1 gene. The plasmid pHRIM807 (PL-xptC1) was constructed by cloning an XhoI fragment from a pHRIM803 into pLEX. This construct was then cut with HpaI/SmaI and religated, thus removing the majority of the xptB1 gene. Plasmid pHRIM808 (PLAC-xptC1) was constructed by removing the AT2 trimethoprim resistance cassette from pHRIM803 with a SalI digest. This construct was cut with XbaI and HpaI, blunt ending with Klenow and religated to form pHRIM808. Figure 1 summarizes the regions of DNA and genes present in each of the plasmid constructed.
![]() View larger version (25K): [in a new window] |
FIG. 1. Fragments of cHRIM1 which are present in plasmid constructs expressing xpt genes. The light-colored boxes show the regions of cHRIM1 which are present in each plasmid specified. Enzyme sites shown are those used in the subcloning (see text). *, BamHI site that was introduced via an AT2 transposon. Sizes are indicated in base pairs.
|
Gene disruptions in Xenorhabdus.
The insecticidal genes of X. nematophilus PMFI296 (xptA1, xptA2, xptB1, and xptC1) were disrupted by insertion of a kanamycin resistance cassette (Pharmacia) into each gene. The first step in this process involved cloning the whole or part of the appropriate insecticidal gene into the multiple cloning site of the suicide vector pHRIM810 described previously. The kanamycin resistance cassette was then inserted into the insecticidal gene present on the suicide plasmid. Figure 2 shows the enzyme sites used for the kanamycin cassette insertion in each gene. The E. coli strain ED8654 harboring PNJ5000 (6) was then transformed with the appropriate gene disruption plasmid. Colonies were selected on LB agar containing kanamycin (50 µg ml-1). Colonies were grown in LB medium containing kanamycin (50 µg ml-1) at 37°C for 18 h and diluted 1/100 into fresh medium. The cultures were incubated at 37°C until an optical density at 600 nm of 0.5 was reached. A 25-ml aliquot was centrifuged (4,000 x g for 10 min at 15°C), and the pellet was washed in 25 ml of LB. The recipient strain was prepared for mating in a similar way. X. nematophilus PMFI296 was grown in 5 ml of LB at 30°C overnight. Cells were collected and washed with 25 ml of LB by centrifugation (4,000 x g for 10 min at 15°C). Both cell pellets were resuspended in 0.2 ml of LB. A subsample, 0.1 ml of each, was mixed and pipetted onto 1.4-cm diameter, 0.2-µm-pore-size nitrocellulose filters that had been placed on LB plates. Samples were incubated for 16 h at 30°C. Growth on the filter was scraped into 1 ml of LB and vortexed to resuspend the cells. Transconjugates were selected by plating these cells onto LB agar containing 100 µg of ampicillin ml-1 and 50 µg of kanamycin ml-1, taking advantage of Xenorhabdus species natural resistance to ampicillin. The X. nematophilus PMFI296 strains containing each gene disruption plasmid were grown in 5 ml of LB containing 25 µg of kanamycin ml-1 for 16 h at 30°C, and dilutions were plated on LB agar containing 25 µg of kanamycin ml-1 and 5% (wt/vol) sucrose. After incubation at 30°C for 48 h, colonies that grew through the sucrose selection were screened for plasmid loss by testing for chloramphenicol resistance. Colonies that were chloramphenicol sensitive were characterized by Southern blot analysis to confirm insertional inactivation within the correct gene. For the Southern blot, DNA was obtained from the strains using Qiagen chromosomal DNA kit, restricted with EcoRI and HindIII, and probed with digoxigenin-labeled PCR products approximately 500 bp in length that corresponded to the inactivated gene. The probes were chosen such that different size fragments would be highlighted for HindIII- and EcoRI-restricted DNA from the wild type, the insertion mutant, and the suicide plasmid. In each case the Southern blot revealed a single band corresponding to the correct predicted size for the insertion mutant (data not shown).
![]() View larger version (15K): [in a new window] |
FIG. 2. Location of gene disruptions on the X. nematophilus PMFI296 chromosome. Arrows show the location and orientation of each kanamycin cassette. The enzyme sites shown are those that were used to introduce the cassette into each gene disruption plasmid. Sizes are indicated in base pairs.
|
for 20 s, and the potency of the lysate or a mixture of lysates was tested in incorporation assays. These were performed by spreading 50 µl of lysate onto agar based artificial diet (3) which contained streptomycin (20 µg ml-1) and cefotaxime and tetracycline (each at 100 µg ml-1) in plastic containers (diameter, 4.5 cm). After the surface had dried, 10 larvae were added and containers were incubated at 25°C (16-h day-length period) and relative humidity of 80%. Recordings of larval mortality were taken after 24 h. A positive result was scored if all larvae were dead, and a negative result if no larvae had died. In the assays negative controls included treatments with just buffer (PBS) and E. coli cells containing pLEX. More detailed bioassays to study the activity of X. nematophilus PMFI296, disruption mutants, and E. coli clones against neonate P. brassicae, Heliothis virescens, and Plutella xylostella, as well as E. coli clones against Pieris rapae larvae were performed as follows. Cell samples of X. nematophilus PMFI296 and the disruption mutants were each prepared from cultures grown for 72 h at 25°C on eight 9-cm-diameter petri plates containing L agar. Cells were harvested, suspended in 200 ml of PBS, washed by centrifugation at 6,000 x g for 10 min, and resuspended in 15 ml of 5% (wt/vol) lactose. Cell suspensions were then frozen at 70°C for 4 h and freeze-dried at -60°C for 48 h. For E. coli, cells were cultured in 200 ml of LB containing 50 µg of ampicillin ml-1 for 40 h at 30°C. Cells were harvested by centrifugation, washed once in PBS, and suspended in 8 ml of PBS. The cells were then lysed by sonication using three bursts of 20 s at 18
. To the cell lysate, 8 ml of 10% lactose (wt/vol) was added, and the resulting cell suspension was frozen and freeze-dried as described above. To measure the amount of total protein present in the freeze-dried samples the bicinchoninic acid protein assay kit (Pierce, Rockford, Ill.) was used, and the manufacturer's instructions were followed. The amount of XptA1, XptA2, and XptC1 in the material was calculated by analyzing the samples by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and calculating the relative intensity of the appropriate toxin band to the sum of all the other bands using Phoretix 1D Analysis Software (version 4.01; BioGene). The same freeze-dried samples were used in all experiments to ensure the amount of toxin protein in the samples remained constant. To determine the potency of the bacterial samples each was tested in triplicate using multidose assays on artificial diet. These were performed using a series of five dilutions for each sample. For each dilution, 50-µl duplicates of bacterial suspension was tested against P. brassicae, P. rapae, and P. xylostella in spread assays as already explained. For H. virescens, four containers per dilution were used, to which five larvae were added. Recordings of P. brassicae, P. rapae, and P. xylostella larval mortality were taken after 6 days. For H. virescens, activity was measured as reduction in larval weight compared to that of untreated controls after 5 days of growth at 25°C. In all the assays, negative controls included treatments with just PBS. The results of the assays were evaluated by Logit transformation using Genstat (5th edition; VSN International Ltd.) to determine the 50% lethal concentration (LC50) and the concentration required to cause a 50% reduction in larval weight compared to an untreated control (EC50).
SDS-PAGE of cell proteins.
E. coli clones were grown in induction media for 16 h and cells were harvested by centrifugation at 13,000 x g for 5 min. The cell pellet was resuspended in one-eighth of the original volume of PBS. Samples (5 µl) were added to equal volumes of 2x SDS-PAGE loading buffer (100 mM Tris HCl, pH 6.8; 1% mercaptoethanol; 4% SDS; 20% glycerol; 0.2% bromophenol blue) before being placed in a boiling water bath for 5 min. Samples were then loaded onto 3 to 8% precast gradient gels (Novex, San Diego, Calif.), which were run at 150 V for 1.5 h. Gels were stained with 0.25% (wt/vol) Coomassie brilliant blue in 40% (vol/vol) methanol-10% (vol/vol) acetic acid for 1 h and destained for 3 h.
|
|
|---|
![]() View larger version (99K): [in a new window] |
FIG. 3. SDS-PAGE of cell lysates from E. coli clones expressing xpt genes. Lanes: 1, GI724(PL); 2, GI724(PL-xptA1); 3, GI724(PL-xptA2); 4, GI724(PL-xptB1) 5, GI724(PL-xptC1); 6, GI724(PL-xptB1/C1). Markers are indicated at left.
|
|
View this table: [in a new window] |
TABLE 1. Effect on P. brassicae of mixing lysates from strains of E. coli expressing different xpt genes
|
|
View this table: [in a new window] |
TABLE 2. Activity of lysates from single xpt genes and combinations of cloned xpt genes in E. coli GI724
|
|
View this table: [in a new window] |
TABLE 3. The activity of X. nematophilus gene knockout mutants and cloned toxin genes found to supplement insect activity
|
PMFI (xptA1::kan) mutants showed activity comparable to the wild type against H. virescens, confirming that this gene was not involved in activity towards this insect, and that lack of expression of XptA1 did not change expression or activity of xptA2, xptC1, and xptB1. However xptA2 and xptB1xptC1 disruptions reduced significantly the activity towards H. virescens. Addition of XptA2 to PMFI296(xptA2::kan) strains did not restore insecticidal activity to H. virescens confirming previous results that xptC1 and xptB1 were also silenced. Insecticidal activity for strains with xptC1 and xptB1 gene disruptions could be complemented with XptC1/XptB1 produced in the same E. coli strain. However, insecticidal activity could not be restored by adding lysate from E. coli expressing singly either xptB1 or xptC1, for their respective gene disruptions. These results follow the same pattern that was observed for activity of PMFI xpt disruption mutants against P. brassicae.
|
|
|---|
Also, importantly, the effect of these genes on two commercial pests, P. rapae and H. virescens, has been elucidated, and it has been found that different spectrums of activity can be achieved by substituting different xptA genes with the same xptB1-xptC1 construct. This is important because to date, the effect of the toxin genes of Photorhabdus and Serratia have only been studied in detail on the model insect M. sexta and on Costelytra zealandica, which is a pest of New Zealand grasslands. Further adding to our understanding of xpt like genes are the findings that the interaction between XptA1 and XptB1/C1 can occur in vitro by mixing cell lysate, but the interaction of the xptB1 and xptC1 genes requires their expression in the same bacterial cell.
Interestingly, disruption of the xptC1, xptB1, or xptA2 genes reduced the activity of PMFI296 mutants against P. xylostella by more than 30-fold (Table 3). However, when lysate from an E. coli expressing xptA2 was mixed with a lysate of E. coli expressing xptB1 and xptC1 no activity towards P. xylostella was observed (Table 2). Therefore, there is possibly another unidentified insecticidal toxin gene in PMFI296, which requires XptB1/XptC1 proteins for activity and is responsible for activity towards P. xylostella. Alternatively the xptA2 gene may be responsible for such activity but is inactive in E. coli due to lower levels of expression or other factors present in Xenorhabdus but lacking in E. coli. The latter is more likely since xptA2 is highly expressed in PL-xptA2 constructs.
Previous work on XptA-like toxins in P. luminescens showed that single purified XptA1 like proteins were sufficient for toxicity (5), but when the genes coding for these proteins were expressed in E. coli, insect activity was not conferred (1). In light of the present work and other research (13), one explanation for this could be that tiny undetectable amounts of XptC1 and XptB1 like proteins may have contaminated the protein preparation in these protein studies, and contributed to the toxicity observed. Alternatively, processing of the XptA1 protein by XptC1 and XptB1 like proteins may have occurred in the Photorhabdus cell before purification. Therefore, the proteins purified represent the processed or active forms of XptA1.
From the results presented here, processing of an inactive XptA type protein by the XptB1/C1 complex to produce an active XptA protein remains a possible theory. The fact that XptA1 shows slight toxic effects on its own, alongside the fact that purified homologues from P. luminescens W-14 were active supports this theory. The different spectrum of activities exhibited by XptA1 and XptA2 is also consistent with this theory. If this is the case then it seems likely that the XptB1/C1 complex is capable of activating a range of XptA like molecules with differing spectrums of activity. Such activation of any XptA1 like proteins may not be easy to detect because SDS-PAGE and matrix-assisted laser desorption-ionization time-of-flight analysis showed that the size of the active purified TcaA and TcaB proteins were equal to the size predicted by their ORFs (5). In our experiments no differences in the protein pattern of XptA1 was observed when expressed alone, or in the presence of XptB1/C1. Therefore, protease activity or any covalent modification by the XptB1/C1 complex that increases or decreases the size of the XptA1 protein significantly, is unlikely.
Coexpression of tcdA (xptA-like) and tcdB (xptC-like) in E. coli resulted in formation of a phage-like structure, visible in toxic particulate preparations. Expressing tccC (xptB-like) in the same cell as tcdA and tcdB does not alter these structures but renders them orally toxic (13). We have looked at crude lysates from recombinant E. coli and have been unable to observe these structures. However, our expression constructs, unlike those used for expressing tcdA and tcdB, do not contain phage-like genes such as lysR. In addition, our cultures are also not induced with UV, which may result in expression of endogenous prophage proteins. Both of these factors may aid in the formation of phage-like structures seen with recombinant tcdA and tcdB. If formation of these phage-like structures is essential for toxicity, then such formation would have to take place outside the cell since xptA1/xptA2 and xptB1/C1 lysates can be mixed in vitro to produce insect activity.
In this study the interactions seen with E. coli expressed proteins was reflected in those expressed in the wild type Xenorhabdus strain. This moves the interactions recorded away from transcriptional and translational interactions, to posttranscriptional modifications or protein interactions. These interactions are not additive. This study showed that xptA2, xptC1, and xptB1 were expressed as a single polycistronic message, and xptA1 was expressed independently. Disruptions in xptA2 using a trimethoprim gene cassette with no transcriptional terminator allowed the expression of the downstream genes xptC1 and xptB1, and maintenance of activity against P. brassicae (12). In this study, disruption of xptA2 with a kanamycin resistance gene cassette with a transcriptional terminator, prevented downstream expression of xptC1 and xptB1 and loss of insecticidal activity. Therefore in Xenorhabdus, the genes xptA2, xptB1, and xptC1 are colocalized and are expressed on a polycistronic message from promoters that also function in E. coli. In P. luminescens W14, the genes tcb, tcd, tca, and tca are clearly different in this regard, since they are distributed separately over the chromosome, and expressed individually from inducible phage-like promoters (2). They are also expressed in an uncoordinated fashion at different times during growth. In Serratia although the sep genes are more tightly grouped, an ORF still separates sepB and sepC and there is no xptA1-like gene equivalent in the arrangement. Thus, the arrangement of these genes in Xenorhabdus may represent a more evolved structure, where over time distal mobile genes which are able to interact for a beneficial effect, i.e., insect toxicity, have, through numerous integration events, formed a tightly integrated unit.
Clearly questions remain relating to how xpt gene products interact to form an active toxin. Since XptA1 and XptA2 individually and XptB1 and XptC1 combined show a low level of insecticidal activity, they may all be active toxins. In this way the interaction of the toxins, either before they come into contact with the target cell, or after this interaction, could result in an effect which kill insects quicker. However, the fact that we now have individual proteins expressed at high levels in E. coli and some combinations are active when mixed in vitro, this will help answer some of these questions. Further studies on purified proteins expressed in E. coli and their interactions are needed.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»